Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 415

1.

The Prader-Willi syndrome: a study of 40 patients and a review of the literature.

Bray GA, Dahms WT, Swerdloff RS, Fiser RH, Atkinson RL, Carrel RE.

Medicine (Baltimore). 1983 Mar;62(2):59-80. Review.

PMID:
6338343
2.
3.
4.

The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.

Gunay-Aygun M, Schwartz S, Heeger S, O'Riordan MA, Cassidy SB.

Pediatrics. 2001 Nov;108(5):E92.

PMID:
11694676
5.

Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.

Angulo M, Castro-Magana M, Mazur B, Canas JA, Vitollo PM, Sarrantonio M.

J Pediatr Endocrinol Metab. 1996 May-Jun;9(3):393-400.

PMID:
8887149
6.

Growth hormone secretion in Prader-Willi syndrome.

Costeff H, Holm VA, Ruvalcaba R, Shaver J.

Acta Paediatr Scand. 1990 Nov;79(11):1059-62.

PMID:
2267923
7.

A reduced number of insulin receptors in patients with Prader-Willi syndrome.

Kousholt AM, Beck-Nielsen H, Lund HT.

Acta Endocrinol (Copenh). 1983 Nov;104(3):345-51.

PMID:
6356745
8.
9.

Hypogonadism and endocrine metabolic disorders in Prader-Willi syndrome.

Müller J.

Acta Paediatr Suppl. 1997 Nov;423:58-9. Review.

PMID:
9401541
10.

Energy expenditure and body composition in Prader-Willi syndrome.

Schoeller DA, Levitsky LL, Bandini LG, Dietz WW, Walczak A.

Metabolism. 1988 Feb;37(2):115-20.

PMID:
3340003
11.

Endocrine function in the Prader-Willi syndrome.

Jeffcoate WJ, Laurance BM, Edwards CR, Besser GM.

Clin Endocrinol (Oxf). 1980 Jan;12(1):81-9.

PMID:
6769611
12.

Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome.

Grugni G, Guzzaloni G, Moro D, Bettio D, De Medici C, Morabito F.

Clin Endocrinol (Oxf). 1998 Jun;48(6):769-75.

PMID:
9713567
14.

Somatropin therapy in adults with Prader-Willi syndrome.

Höybye C, Thorén M.

Treat Endocrinol. 2004;3(3):153-60. Review.

PMID:
16026111
15.

[Prader-Willi syndrome associated with chromosomal aberration: report of a case].

Kokura K, Shima H, Mori Y, Ikoma F, Sakamoto H, Furuyama J.

Hinyokika Kiyo. 1992 Sep;38(9):1079-82. Japanese.

16.

Deletion of chromosome 15 (q11-13) in a Prader-Labhart-Willi syndrome clinic population.

Cassidy SB, Thuline HC, Holm VA.

Am J Med Genet. 1984 Feb;17(2):485-95.

PMID:
6336316
17.

Body fat excess and stimulated growth hormone levels in adult patients with Prader-Willi syndrome.

Grugni G, Crinò A, Bertocco P, Marzullo P.

Am J Med Genet A. 2009 Feb 15;149A(4):726-31. doi: 10.1002/ajmg.a.32713.

PMID:
19267411
18.

Standard growth curves for Japanese patients with Prader-Willi syndrome.

Nagai T, Matsuo N, Kayanuma Y, Tonoki H, Fukushima Y, Ohashi H, Murai T, Hasegawa T, Kuroki Y, Niikawa N.

Am J Med Genet. 2000 Nov 13;95(2):130-4.

PMID:
11078562
19.

Standards for selected anthropometric measurements in Prader-Willi syndrome.

Butler MG, Meaney FJ.

Pediatrics. 1991 Oct;88(4):853-60.

PMID:
1896298
20.

Peculiar body composition in patients with Prader-Labhart-Willi syndrome.

Brambilla P, Bosio L, Manzoni P, Pietrobelli A, Beccaria L, Chiumello G.

Am J Clin Nutr. 1997 May;65(5):1369-74.

PMID:
9129464

Supplemental Content

Support Center